Sanket Shah, General Counsel & Corporate Secretary at EDAP TMS SA (FOCL), bought 5,000 shares at $4.75 ($24K) on 2026-08-14, disclosed to the SEC on 2026-08-17.
General Counsel Sanket Shah purchased 5,000 shares for $23,750 at $4.75, marking the largest insider purchase in the company's history, signaling confidence in the stock's recent momentum. This significant buy comes on the heels of a strong Q2 earnings report where HIFU revenue surged 39%.
The stock is currently trading at $4.75, which is a 0.8% discount to the analyst fair value estimate of $8.50 cited on July 19, 2026. Following the Q2 earnings release on August 14, 2026, the stock surged 6.2% as reported by Zacks on August 5, 2026.
Q2 2026 earnings on August 14, 2026, which showed HIFU revenue surging 39% year-over-year. The company's expansion into BPH and endometriosis markets, funded by an equity raise, as detailed in the Q2 earnings call highlights on August 14, 2026. Analyst price targets revised upward to $8.50 on July 19, 2026, indicating potential upside from the current price.
The stock is currently trading at a significant discount to the analyst fair value estimate of $8.50, which could indicate overvaluation or a disconnect between fundamentals and market sentiment. The recent surge in share price on August 5, 2026, was accompanied by a note suggesting that trend in earnings estimate revisions does not suggest further strength down the road.
Nothing distinguishes this filing.